Cargando…

Experimental models of fatty liver diseases: Status and appraisal

Fatty liver diseases, including alcohol-associated liver disease (ALD) and nonalcoholic fatty liver disease nonalcoholic fatty liver disease (NAFLD), affect a large number of people worldwide and become one of the major causes of end-stage liver disease, such as liver cirrhosis and hepatocellular ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hua, Shen, Haiyuan, Seo, Wonhyo, Hwang, Seonghwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309509/ https://www.ncbi.nlm.nih.gov/pubmed/37378635 http://dx.doi.org/10.1097/HC9.0000000000000200

Ejemplares similares

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
por: Hwang, Seonghwan, et al.
Publicado: (2022)

MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types
por: Wang, Xiaolin, et al.
Publicado: (2021)

In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
por: Soret, Pierre-Antoine, et al.
Publicado: (2020)

Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases
por: Hwang, Seonghwan, et al.
Publicado: (2021)

Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease
por: Yang, Yoon Mee, et al.
Publicado: (2022)

Experimental models of metabolic and alcoholic fatty liver disease
por: Buyco, Delfin Gerard, et al.
Publicado: (2021)

Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease
por: Zhou, Liangliang, et al.
Publicado: (2022)

Exosomes: Nomenclature, Isolation, and Biological Roles in Liver Diseases
por: Park, Seol Hee, et al.
Publicado: (2023)

Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice
por: Cho, Ye Eun, et al.
Publicado: (2023)

Current status of imaging in nonalcoholic fatty liver disease
por: Li, Qian, et al.
Publicado: (2018)

Ethanol and its Nonoxidative Metabolites Promote Acute Liver Injury by Inducing ER Stress, Adipocyte Death, and Lipolysis
por: Park, Seol Hee, et al.
Publicado: (2022)

Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
por: Jin, Yujin, et al.
Publicado: (2023)

Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
por: Ore, Ayokanmi, et al.
Publicado: (2019)

An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease
por: Emamat, Hadi, et al.
Publicado: (2016)

Experimental Data on the Role of Melatonin in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Terziev, Dimitar, et al.
Publicado: (2023)

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
por: Fang, Tingyu, et al.
Publicado: (2022)

Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake
por: Hwang, Seonghwan, et al.
Publicado: (2020)

A Critical Appraisal of the Definition of Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease: Pitfall of Adjusted Muscle Mass by Body Weight
por: Park, Huiyul, et al.
Publicado: (2020)

Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats
por: Lessa, Andréia S, et al.
Publicado: (2010)

Current status, problems, and perspectives of non-alcoholic fatty liver disease research
por: Tanaka, Naoki, et al.
Publicado: (2019)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications
por: Guo, Gong-Jing, et al.
Publicado: (2023)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
por: Dooghaie Moghadam, Arash, et al.
Publicado: (2020)

Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
por: Aasadollahei, Negar, et al.
Publicado: (2023)

Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
por: Li, Xiaoyan, et al.
Publicado: (2020)

Immunological mechanisms and therapeutic targets of fatty liver diseases
por: Wang, Hua, et al.
Publicado: (2020)

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases
por: Han, Dong Wook, et al.
Publicado: (2023)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis
por: Ninomiya, Masashi, et al.
Publicado: (2012)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal
por: Bozic, Dorotea, et al.
Publicado: (2022)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
por: Xiao, Meng-Wei, et al.
Publicado: (2019)

Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
por: Jiang, Mingzuo, et al.
Publicado: (2019)

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
por: Vajro, Pietro, et al.
Publicado: (2012)

Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment
por: Königs, Anja, et al.
Publicado: (2016)

E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9
por: Rodrigues, Robim M., et al.
Publicado: (2021)

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
por: Zhu, Xiaopeng, et al.
Publicado: (2016)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vi9an8nfipv724l2qlamq40iu4